Sökresultat

Filtyp

Din sökning på "*" gav 121443 sökträffar

2020

Articles Hettne, Jörgen & Maria Fritz, Rättsfall från EU-domstolarna, i Ny juridik, 2020 I Hydén, Håkan & Woodlock, John, (f)Lex avionica; How soft law serves as an instrumental mediator between professional norms and the hard law regulation of European civil aviation maintenance, i Safety Science, 2020 I Nordberg, Ana & Mattsson, Titti, COVID-19 Pandemic in Sweden: Measures, Policy approach and L

https://www.aclu.lu.se/en/publications/other-works/2020 - 2025-06-23

2019

Articles Flodgren, Boel (2019), Felparkeringsrätt - hellre fälla än fria? Del 2, Juridisk tidskrift vid Stockholms Universitet 2019/20 Flodgren, Boel (2019), Felparkeringsrätt - hellre fälla än fria? Juridisk tidskrift vid Stockholms Universitet 2019/20 Hardenberger, Alexander (2019), Bevisbördans placering i fordringsmål II - särskilt om förhållandet mellan den civilrättsliga regeln och föremålet

https://www.aclu.lu.se/en/publications/other-works/2019 - 2025-06-23

2018

Articles Bogdan, M (2018). Regulation Brussels Ia and violations of personality rights on the internet - Nordic Journal of International Law. Dotevall, R (2018). Har styrelsen en plikt att försätta bolaget i konkurs? - Nyheter från ackordcentralen.   Dotevall, R (2018). Groups of Companies In Swedish Law - Journal of Civil & Legal Science. Ingvarson, A & Utterström, M (2018). Självkostnadsprincipe

https://www.aclu.lu.se/en/publications/other-works/2018 - 2025-06-23

2017

Articles Arvidsson, N (2017). Privat reglering av revisorsval i aktiebolag: En analys av ogiltighet enligt 9 kap. 16 a § ABL - Svensk Juristtidning. Bogdan, M (2017). The new EU rules on electronic insolvency registers - Masaryk University Journal of Law and technology. Bogdan, M & Persson, V (2017). Några synpunkter med anledning av Europadomstolens Arlewindom - Svensk Juristtidning. Ingvarson, A

https://www.aclu.lu.se/en/publications/other-works/2017 - 2025-06-23

Student

ACLU welcome all students that are interested in business law questions to participate in the different events of the centre. Our seminars and lectures occur frequently throughout the year, and enable researchers, students and legal professionals to exchange knowledge on business law. In addition, our intention is to arrange a seminar aimed solely to students. Are you a student and want to know mo

https://www.aclu.lu.se/en/student - 2025-06-23

Contact

General questions E-mail: aclu [at] jur [dot] lu [dot] se (aclu[at]jur[dot]lu[dot]se)Telephone: +46 46 222 10 73You are also welcome to contact any of the people below. Head of ACLU Patrik Lindskoug Associate Professor Email: patrik [dot] lindskoug [at] jur [dot] lu [dot] se Telephone: +46 46 222 10 18 Research Portal Graduate Research Assistant Andrea Ekdahl Email: andrea [dot] ekdahl [at] jur [d

https://www.aclu.lu.se/en/contact - 2025-06-23

Innovation projects supported by MultiPark

Distinguishing taupathies by kinetic analysis of reproducibility-optimized RT-quic experiments - Alexander DearPersonalized diagnosis and prognosis of Alzheimer´s disease - O Hansson, N Mattsson-Carlgren, S PalmqvistThe Alzheimer patient’s clinical cell biology - Hansson, Parmar, ToressonA new drug screening strategy for Huntington’s disease using induced neurons - Johan JakobssonPathophysiology-g

https://www.multipark.lu.se/innovation/innovation-projects-supported-multipark - 2025-06-23

Research Groups

Senior Researchers Ahlenius, Henrik - Stem Cells, Aging and NeurodegenerationBjörklund, Anders - affiliated with Developmental Neurobiology LabBjörklund, Tomas - Molecular Neuromodulation UnitBjörkqvist, Maria - Biomarkers in Brain DiseaseCenci Nilsson, Angela - Basal Ganglia PathophysiologyDeierborg, Tomas - NeuroinflammationEnglund, Elisabet - Division of Oncology and PathologyGouras, Gunnar - E

https://www.multipark.lu.se/research/research-groups - 2025-06-23

Integrative Neurophysiology and Neurotechnology (LU & UmU)

Our research We investigate how different parts of the central nervous system interact to generate purposeful behaviors. In particular, we study how the cerebral cortex and the basal ganglia interact to control motor actions, both under normal conditions and in individuals afflicted by Parkinson’s disease. In our previous work, we have studied motor control functions, ranging from relatively simpl

https://www.multipark.lu.se/integrative-neurophysiology-and-neurotechnology-lu-umu - 2025-06-23

Basal Ganglia Pathophysiology

Our research The brain´s basal ganglia elaborate information from multiple sources to shape and select our movements and thoughts. These functions are heavily dependent on signals that originate from dopamine cells in the midbrain. Dopamine cells degenerate in Parkinson´s disease (PD) giving rise to typical motor and non-motor deficits. With our research, we pursue pathophysiological mechanisms an

https://www.multipark.lu.se/basal-ganglia-pathophysiology - 2025-06-23

Behavioral Neuroscience Laboratory

Andreas Heuer Our research We are interested in preclinical rodent models of neurodegenerative diseases with a focus on non-motor symptoms. We use these models to test treatments like cell replacement therapy and gene therapy. For that purpose, we use technologies that allow for the reversible manipulation of cell activity (opto- and chemogenetics), technologies that allow for the recording of neu

https://www.multipark.lu.se/behavioral-neuroscience-laboratory - 2025-06-23

Other Strategic Grants

Other strategic grants give you the opportunity to obtain co-funding when inviting scientific guests to give lectures or when organizing scientific conferences. The granted amount can be used to cover travel and accommodation costs in connection with the event. Please indicate if food/drinks are requested and indicate an amount. Costs for subsistence allowance (“traktamente”) are not eligible. Tri

https://www.multipark.lu.se/funding-opportunities/other-strategic-grants - 2025-06-23

Experimental Neuroinflammation Laboratory

Our research Our projects focus is to investigate the role of neuroinflammation in neurodegenerative disorders, including Alzheimer’s disease, Parkinson’s disease and stroke. Microglia are the major immune cells in the brain. Therefore, the majority of our projects aim to explore the function of these cells and to determine how they contribute to health and disease. In addition, we investigate how

https://www.multipark.lu.se/experimental-neuroinflammation-laboratory - 2025-06-23

Experimental Dementia Research

Our research Dementia is a major public health concern globally but treatments have so far been inadequate. Our focus is to understand the early molecular and cellular pathology that we see initiating in synapses in Alzheimer’s disease, the most common neurodegenerative disease. It remains imperative that academic researchers uncover early steps in the disease process, rather than only translating

https://www.multipark.lu.se/experimental-dementia-research - 2025-06-23

Human Neural Development

Our research The human brain is a highly complex structure, consisting of hundreds of different subtypes of neurons; each of which fulfill a specific function in the brain network. When some of these neurons are lost – such as in neurodegenerative diseases – our brains become malfunctioning. The goal of our research is to develop stem cell-based therapies to replace lost neurons as a treatment for

https://www.multipark.lu.se/human-neural-development - 2025-06-23

Nanobiotechnology and Lab-on-a-chip

Our research We develop new microfluidic and acoustofluidic technology to create spatially and temporally controlled microenvironments for cell culturing and to manipulate biological matter in the microscale. This will provide new strategies for stem cell differentiation, novel means to study cell/tissue drug response, and new techniques for cell separation as well as submicron particle separation

https://www.multipark.lu.se/nanobiotechnology-and-lab-chip - 2025-06-23

Rehabilitation Medicine

Our research We conduct research and education with a focus on disability and rehabilitation. The target groups are individuals of all ages with neurologic disabilities as a result of stroke, traumatic brain injury, spinal cord injury, post-polio, multiple sclerosis, Parkinson’s disease, and neuromuscular disorders, and children, adolescents and adults with non-malignant pain. The research group i

https://www.multipark.lu.se/rehabilitation-medicine - 2025-06-23

CNS Gene Therapy

Our research In the gene therapy group, our main interest is to develop systems for sufficient and sustained expression of transgenes in the CNS. We are using gene transfer to express trophic factors or neurotransmitter-producing enzymes in animal models of neurodegenerative disease. We are currently working with three different vector systems: adeno-associated viral, retroviral and lentiviral. Th

https://www.multipark.lu.se/cns-gene-therapy - 2025-06-23